Learn about CVE-2019-18246 affecting BIOTRONIK CardioMessenger II products. Discover the impact, technical details, and mitigation steps for this authentication vulnerability.
BIOTRONIK CardioMessenger II products have a vulnerability related to improper authentication, potentially allowing unauthorized access to the remote communication infrastructure.
Understanding CVE-2019-18246
The vulnerability in BIOTRONIK CardioMessenger II products stems from a lack of proper mutual authentication implementation with the BIOTRONIK infrastructure for remote communication.
What is CVE-2019-18246?
The affected products fail to enforce mutual authentication, which could lead to unauthorized access to the BIOTRONIK Remote Communication infrastructure.
The Impact of CVE-2019-18246
This vulnerability could be exploited by malicious actors to gain unauthorized access to the communication infrastructure, potentially compromising sensitive data and system integrity.
Technical Details of CVE-2019-18246
The technical aspects of the CVE-2019-18246 vulnerability are as follows:
Vulnerability Description
The BIOTRONIK CardioMessenger II products do not effectively implement mutual authentication with the infrastructure for remote communication provided by BIOTRONIK.
Affected Systems and Versions
Exploitation Mechanism
Unauthorized users could exploit this vulnerability to gain access to the BIOTRONIK Remote Communication infrastructure without proper authentication.
Mitigation and Prevention
To address CVE-2019-18246, follow these mitigation steps:
Immediate Steps to Take
Long-Term Security Practices
Patching and Updates
BIOTRONIK may release patches or updates to address the vulnerability. Ensure timely installation of these updates to mitigate the risk of exploitation.